罗氏试剂盒说明书英文原版 proBNP II 04842464 190 V8.0.pdfVIP

ms_04842464190V8.0 proBNP II N-terminal pro B-type natriuretic peptide REF SYSTEM Elecsys 2010 MODULAR ANALYTICS E170 190 100 cobas e 411 cobas e 601 cobas e 602 English remodelling, and therefore contributes to the establishment of individualized rehabilitation procedures.20,21 Intended use Immunoassay for the in vitro quantitative determination of N‑terminal pro NT‑proBNP also represents cardiac function and indicates increased risk in B‑type natriuretic peptide in human serum and plasma. This assay is patients scheduled for potentially cardiotoxic drugs or interventions causing indicated as an aid in the diagnosis of individuals suspected of having fluid retention or volume overload (e.g. COX‑2 inhibitors, nonsteroidal congestive heart failure and detection of mild forms of cardiac dysfunction.1, anti‑inflammatory drugs).22,23,24,25,26,27,28,29,30,31,32,33 2,3,4,5,6 The test also aids in the assessment of heart failure severity in The Elecsys proBNP II assay contains two mon